Trial Condition(s):

Bacterial Infections

Ciprofloxacin oral suspension administered for 3 days versus ciprofloxacin oral suspension administered for 5 days in children and juveniles for the treatment of Shigella dysenteriae type one dysentery

Bayer Identifier:

Trial_0570

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
253
Trial Dates
black-arrow
Phase
3
Could I receive a placebo?
No
Products
Cipro (Ciprofloxacin, BAYQ3939)
Accepts Healthy Volunteers
N/A

Where to Participate

Locations
Status
LocationsStatus

For details, please refer to trial results

Additional Information